Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6836071 | 0.79 | KDM4E (0.32) | KDM4EALDH1A1POLBALOX15 | |
| SCHEMBL4787578 | 0.76 | KDM4E (0.41) | KDM4EALDH1A1POLBALOX15 | |
| SCHEMBL1977356 | 0.76 | KDM4E (0.45) | KDM4EALDH1A1IDO1TDO2POLB | |
| SCHEMBL15922747 | 0.76 | KDM4E (0.45) | KDM4EALDH1A1IDO1TDO2POLB | |
| SCHEMBL13346247 | 0.74 | KDM4E (0.40) | KDM4EALDH1A1POLBALOX15 | |
| SCHEMBL13346243 | 0.73 | KDM4E (0.39) | KDM4EALDH1A1POLBALOX15 | |
| SCHEMBL13346246 | 0.73 | KDM4E (0.39) | KDM4EALDH1A1POLBALOX15 | |
| SCHEMBL13346245 | 0.73 | KDM4E (0.39) | KDM4EALDH1A1POLBALOX15 | |
| SCHEMBL13346240 | 0.73 | KDM4E (0.39) | KDM4EALDH1A1POLBALOX15 | |
| SCHEMBL13346242 | 0.73 | KDM4E (0.39) | KDM4EALDH1A1POLBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6784268-B2 | POLAR ALKYLOXYALKYL-SUBSTITUTED NORBORN-2-ENES, PENTALENES, 4,7-METHANOINDENES HAVING A ACID LABILE GROUP AS MONOMERS FOR HIGH-MOLECULAR WEIGHT POLYMERS; SUBSTRATE ADHESION; RIGIDITY; RESOLUTION AND ETCH RESISTANE; MICROPATTERNS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-08-31 | — | — | US | disclosed |
| US-20040013973-A1 | Ether, polymer, resist composition and patterning process | SHIN-ETSU CHEMICAL CO,. LTD. (JP) | 2004-01-22 | — | — | US | disclosed |
| US-6624335-B2 | Unsaturated ether compound; photopolymerization | SHIN ETSU CHEMICAL CO., LTD. (JP) | 2003-09-23 | — | — | US | disclosed |
| US-20020161150-A1 | Ether, polymer, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161150-A1 | Ether, polymer, resist composition and patterning process | ARCN1, RER1, GAR1 | KDM4E 132/4885ALDH1A1 1186/4885IDO1 4542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.